Skip to content

Clinical trials

Genetic Predisposition to Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Predisposition to Disease Country / region: United States Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20021
20031
20041
20073
20082
20091
20113
20121
20152
20176
20185
20194
20205
202110
20225
20237
20247
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting28
Unknown status7
Active, not recruiting7
Enrolling by invitation5
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital6
St. Jude Children's Research Hospital6
Abramson Cancer Center at Penn Medicine5
Mayo Clinic4
National Institute of Environmental Health Sciences (NIEHS)4
Boston Children's Hospital3
Dana-Farber Cancer Institute3
M.D. Anderson Cancer Center3
Massachusetts General Hospital3
University of Virginia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Predisposition to Disease85
Genetic Diseases, Inborn12
Breast Neoplasms6
Ovarian Neoplasms5
Neoplasms4
Parkinson Disease4
Prostatic Neoplasms4
Alzheimer Disease3
Colorectal Neoplasms, Hereditary Nonpolyposis3
Disease Susceptibility3

Trials

Showing 76 to 85 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.